DIY artificial pancreas systems: the clinician perspective

人工胰腺 医学 胰岛素泵 胰岛素释放 欧洲联盟 1型糖尿病 食品药品监督管理局 互操作性 胰岛素 糖尿病 医疗保健 重症监护医学 风险分析(工程) 计算机科学 业务 内科学 内分泌学 万维网 经济政策 经济增长 经济
作者
Emma G Wilmot,Thomas Danne
出处
期刊:The Lancet Diabetes & Endocrinology [Elsevier BV]
卷期号:8 (3): 183-185 被引量:20
标识
DOI:10.1016/s2213-8587(19)30416-4
摘要

We are witnessing a technological revolution in type 1 diabetes, with a race to bring commercial closed-loop (artificial pancreas) systems to market. However, only one automated insulin-delivery system, the Medtronic MiniMed 670G, has received both US Food and Drug Administration (FDA) and European CE mark approval and is commercially available in several countries. The French Diabeloop system, designed to work with several continuous glucose monitors and insulin pumps, has received a CE mark, and the FDA have awarded the Tandem Diabetes Care t:slim X2 the status of an alternate controller enabled interoperable pump, facilitating efficient premarket review; however, neither are commercially available yet. Meanwhile, in the European Union, new medical device regulations will be more demanding with respect to safety, potentially slowing access to commercial closed-loop systems. While waiting for these systems to come to market, people living with diabetes have taken development into their own hands, with the #WeAreNotWaiting movement supporting the use of do-it-yourself (DIY) artificial pancreas systems incorporating commercially available insulin pumps and continuous glucose monitors with automated control algorithms. Several DIY artificial pancreas systems are now available for people to build and use, integrating a range of different insulin pumps and glucose sensors. Health-care professional opinions of DIY artificial pancreas systems in the UKType 1 diabetes is one of the most challenging long-term medical conditions to manage. Over the past five years, technologically skilled people with type 1 diabetes have developed communication systems and algorithms that allow insulin delivery from insulin pumps to be automatically controlled. These systems combine glucose data from a continuous glucose monitor with an original algorithm that communicates with an insulin pump to sustain, reduce, or increase insulin delivery to maintain glucose levels within a target range. Full-Text PDF
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
乐乐应助郭飒采纳,获得10
1秒前
bcc666发布了新的文献求助10
1秒前
2秒前
安安应助单纯以云采纳,获得10
2秒前
荷兰香猪完成签到,获得积分10
2秒前
信wz发布了新的文献求助10
3秒前
爆米花应助ST采纳,获得10
3秒前
侯筱涵完成签到,获得积分20
3秒前
Usin完成签到,获得积分10
3秒前
邓李梅完成签到,获得积分10
3秒前
wing完成签到 ,获得积分10
3秒前
开朗孤兰完成签到,获得积分10
4秒前
nh发布了新的文献求助10
5秒前
HBin完成签到,获得积分10
5秒前
脑洞疼应助辛勤芷天采纳,获得10
5秒前
无敌通发布了新的文献求助10
6秒前
6秒前
毕长富完成签到,获得积分10
7秒前
我爱吃小布丁你呢完成签到 ,获得积分10
8秒前
Anima应助bcc666采纳,获得10
8秒前
土块完成签到 ,获得积分10
8秒前
英俊的铭应助zmick采纳,获得10
9秒前
fuzhou完成签到,获得积分10
9秒前
卷卷发布了新的文献求助10
10秒前
10秒前
李成昊完成签到,获得积分10
11秒前
11秒前
邓李梅发布了新的文献求助10
11秒前
脑洞疼应助及禾采纳,获得10
12秒前
在水一方应助及禾采纳,获得10
12秒前
丘比特应助及禾采纳,获得10
12秒前
Baihuashan完成签到 ,获得积分10
12秒前
英姑应助及禾采纳,获得10
13秒前
桐桐应助及禾采纳,获得10
13秒前
万能图书馆应助及禾采纳,获得10
13秒前
哆啦A榕完成签到,获得积分10
13秒前
13秒前
13秒前
13秒前
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Fermented Coffee Market 2000
Constitutional and Administrative Law 500
PARLOC2001: The update of loss containment data for offshore pipelines 500
Critical Thinking: Tools for Taking Charge of Your Learning and Your Life 4th Edition 500
Investigative Interviewing: Psychology and Practice 300
Atlas of Anatomy (Fifth Edition) 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5285299
求助须知:如何正确求助?哪些是违规求助? 4438487
关于积分的说明 13817325
捐赠科研通 4319766
什么是DOI,文献DOI怎么找? 2371149
邀请新用户注册赠送积分活动 1366693
关于科研通互助平台的介绍 1330152